Transjugular intrahepatic portosystemic shunt trends in China: A brief review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Transjugular intrahepatic portosystemic shunt (TIPS) is now considered as a major treatment option for cirrhotic patients with portal hypertension. Globally, it is getting markedly increase attention, and a similar phenomenon is occurring in China. On average, the number of TIPS procedures is increasing at a rate of 15% per year. Published research papers are also continuously growing every year. Similar but unique compared to western countries, most Chinese physicians follow Chinese specialized guidelines when treating patients with portal hypertension. In this review, we briefly introduce the history of TIPS in China, the present and the future of TIPS in China.
Abstract
Transjugular intrahepatic portosystemic shunt (TIPS) is now considered as a major treatment option for cirrhotic patients with portal hypertension. Globally, it is getting markedly increase attention, and a similar phenomenon is occurring in China. On average, the number of TIPS procedures is increasing at a rate of 15% per year. Published research papers are also continuously growing every year. Similar but unique compared to western countries, most Chinese physicians follow Chinese specialized guidelines when treating patients with portal hypertension. In this review, we briefly introduce the history of TIPS in China, the present and the future of TIPS in China.
참고문헌 (20)
- Richter GM, "Transjugular intrahepatic portacaval stent shunt : preliminary clinical results", Radiology, 174, pp.1027~1030 (1990)
- Xu K, "Preliminary report on portal hypertension in liver cirrhosis treated by transjugular intrahepatic portosystemic stent-shunt: analysis of 8 cases", Zhonghua Fangshexue Zazhi, 27, pp.294~297 (1993)
- Zhang JS, "Transjugular intrahepatic portosystemnic stent shunts: early clinical experience", Chin J Med Imaging, 1, pp.33~36 (1993)
- Wu XJ, "Preliminary report on portal hypertension treated by transjugular intrahepatic portosystemic stent shunt", Zhonghua Wai Ke Za Zhi, 32, pp.470~473 (1994)
- Rössle M, "The first decade of the transjugular intrahepatic portosystemic shunt(TIPS) : state of the art", Liver, 18, pp.73~89 (1998)
- Zheng M, "Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients : meta-analysis update", J Clin Gastroenterol, 42, pp.507~516 (2008)
- "Clinical guidelines for transjugular intrahepatic portosystemic shunt", Chin J Radiol, 38, pp.1329~1332 (2004)
- "Consensus on transjugular intrahepatic portosystemic shunt for treatment of cirrhotic portal hypertension", J Clin Hepatol, 30, pp.210~213 (2014)
- "Expert consensus on transjugular intrahepatic portosystemic shunt", J Clin Hepatol, 33, pp.1218~1228 (2017)
- Wu X, "Clinical outcome using the fluency stent graft for transjugular intrahepatic portosystemic shunt in patients with portal hypertension", Am Surg, 79, pp.305~312 (2013)
- Wu Q, "Transjugular intrahepatic portosystemic shunt using the FLUENCY expanded polytetrafluoroethylene-covered stent", Exp Ther Med, 5, pp.263~266 (2013)
- Wu X, "Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension", J Hepatobiliary Pancreat Sci, 17, pp.701~708 (2010)
- Wang Q, "Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding", J Hepatol, 67, pp.508~516 (2017)
- García-Pagán JC, "Early use of TIPS in patients with cirrhosis and variceal bleeding", N Engl J Med, 362, pp.2370~2379 (2010)
- Ryan BM, "A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices", Gastroenterology, 126, pp.1175~1189 (2004)
- Joseph D. Morrison, "Gastric Varices Bleed at Lower Portosystemic Pressure Gradients than Esophageal Varices", Journal of Vascular and Interventional Radiology, 29(5), pp.636~641 (2018), Elsevier BV[DOI]
- Dhanasekaran R, "Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis", Am J Gastroenterol, 105, pp.635~641 (2010)
- Yong Lv, "Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial", Gut, 67(12), pp.2156~2168 (2017), BMJ[DOI]
- Yu Z. Zhuge, "Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease", Liver International, 38(10), pp.1867~1874 (2018), Wiley[DOI]
- Shan S, "How to control highly endemic hepatitis B in Asia", Liver Int, 38(Suppl 1), pp.122~125 (2018)
